These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11307338)

  • 21. Rapidly progressive glomerulonephritis.
    Erwig LP; Rees AJ
    J Nephrol; 1999; 12 Suppl 2():S111-9. PubMed ID: 10688410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute diffuse glomerulonephritis].
    Gekle D
    Med Klin; 1974 Jan; 69(4):121-7. PubMed ID: 4592291
    [No Abstract]   [Full Text] [Related]  

  • 23. Glomerular disease made easier: 1.
    Robertson S; Isles C; More I
    Br J Hosp Med; 1995 Mar 15-Apr 4; 53(6):261-6. PubMed ID: 7767571
    [No Abstract]   [Full Text] [Related]  

  • 24. Towards targeted treatment of glomerulonephritis.
    Atkins RC; Singh AK
    Curr Opin Nephrol Hypertens; 2000 May; 9(3):215-6. PubMed ID: 10847320
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there a role for specific anti-TNF strategies in glomerular diseases?
    Ortiz A; Egido J
    Nephrol Dial Transplant; 1995; 10(3):309-11. PubMed ID: 7792022
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic use of ultrasound in certain chronic kidney diseases].
    Shultsev GP; Speranskiĭ AP; Khanukaeva RM
    Ter Arkh; 1974; 46(3):129-36. PubMed ID: 4828491
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid progressive glomerulonephritis: relapse after prolonged remission.
    Adler S; Bruns FJ; Fraley DS; Segel DP
    Arch Intern Med; 1981 Jun; 141(7):852-4. PubMed ID: 7235804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute nephritic syndrome. Physiopathology, diagnosis].
    Esnault VL
    Rev Prat; 1994 Sep; 44(14):1971-5. PubMed ID: 7939292
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rapidly progressive glomerulonephritis (RPGN): Pathogenesis, pathophysiology, and therapy].
    Shimizu Y; Yamagata K; Koyama A
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():403-7. PubMed ID: 16523922
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of oliguric glomerulonephritis.
    Schreiner GE; Rakowski TA; Argy WP; Marc-Aurele J; Maher JF; Bauer H
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):711-25. PubMed ID: 4803313
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcome of Iranian children with mild post streptococcal glomerulonephritis.
    Gheissari A; Adjodani TS; Hashemi M; Mokhtarian A; Sirous M
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):571-4. PubMed ID: 20427896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A primer on recurrent and de novo glomerulonephritis in renal allografts.
    Ivanyi B
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal failure, glomerulonephritis and glomerular epithelial cell hyperplasia.
    Striker GE; Cutler RE; Huang TW; Benditt EP
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):657-75. PubMed ID: 4803311
    [No Abstract]   [Full Text] [Related]  

  • 35. [Membranoproliferative glomerulonephritis. Variability of a morphologically definable disease].
    Anders D; Bläker F; Gekle D; Kehrberg H
    Klin Padiatr; 1982; 194(3):173-81. PubMed ID: 7132223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary and secondary glomerular diseases].
    Birck R; Banas B
    Dtsch Med Wochenschr; 2011 Apr; 136(14):703-5. PubMed ID: 21448831
    [No Abstract]   [Full Text] [Related]  

  • 37. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.
    de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Bruijn JA; Bajema IM; Hagen EC; Pusey CD;
    J Am Soc Nephrol; 2007 Jul; 18(7):2189-97. PubMed ID: 17596637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of glomerulonephritis in the elderly.
    Kunis CL; Teng SN
    Semin Nephrol; 2000 May; 20(3):256-64. PubMed ID: 10855935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenetic basis of treatment of circulatory disorders in diffuse glomerulonephritis].
    Chernin VV; Mishin VI
    Ter Arkh; 1981; 53(6):37-40. PubMed ID: 7281031
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathology of the kidney in "toxic oil epidemic syndrome".
    Navas-Palacios JJ; Usera-Sárraga G; Gil-Martin R; Gutierrez-Millet V
    J Toxicol Environ Health; 1984; 13(1):1-18. PubMed ID: 6716508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.